Damage to the intestinal stem cell niche can result from mechanical stress, infections, chronic
inflammation or cytotoxic therapies. Progenitor cells can compensate for insults to the stem …

Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage. Experimental
in vitro models that faithfully capture the hallmarks and tumor heterogeneity of OC are …

In vitro 3D organoid systems have revolutionized the modeling of organ development and
diseases in a dish. Fluorescence microscopy has contributed to the characterization of the …

Abstract Model systems with defined genetic modifications are powerful tools for basic
research and translational disease modelling. Fortunately, generating state-of-the-art genetic …

Chromosome segregation errors cause aneuploidy and genomic heterogeneity, which are
hallmarks of cancer in humans. A persistent high frequency of these errors (chromosomal …

Direct targeting of the downstream mitogen-activated protein kinase (MAPK) pathway to
suppress extracellular-regulated kinase (ERK) activation in KRAS and BRAF mutant colorectal …

Survival rates of cancer patients vary widely within and between malignancies. While genetic
aberrations are at the root of all cancers, individual genomic features cannot explain these …

Wnt dependency and Lgr5 expression define multiple mammalian epithelial stem cell types.
Under defined growth factor conditions, such adult stem cells (ASCs) grow as 3D organoids …

Central to tumor evolution is the generation of genetic diversity. However, the extent and
patterns by which de novo karyotype alterations emerge and propagate within human tumors …

Patient-derived organoids (PDOs) are widely heralded as a drug-screening platform to
develop new anti-cancer therapies. Here, we use a drug-repurposing library to screen PDOs of …